Muh Akbar Bahar

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

Nutrients

Pharmacology research & perspectives

Infection and drug resistance

Pharmacoepidemiology and drug safety

Rijksuniversiteit Groningen

Rijksuniversiteit Groningen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rijksuniversiteit Groningen

Netherlands

Researcher :: Pharmaco-Therapy, Epidemiology, Economics (PTEE)

Universitas Hasanuddin

Indonesia

Researcher and Lecturer :: Pharmacy

Labuang badji hospital

Indonesia

Pharmacist :: Emergency Unit

Education History

Rijksuniversiteit Groningen

Netherlands

PHD :: Pharmaco-Therapy, Epidemiology, Economics (PTEE)

Universitas Hasanuddin

Indonesia

BSC :: Pharmacy

Publications

Ikhwan Yuda Kusuma, Habibie Habibie, Muh Akbar Bahar, Ferenc Budan, Dezső Csupor
Anticancer Effects of Secoiridoids-A Scoping Review of the Molecular Mechanisms behind the Chemopreventive Effects of the Olive Tree Components Oleocanthal, Oleacein, and Oleuropein. Nutrients 16 (16) (2024)
András Érszegi, Réka Viola, Muh Akbar Bahar, Barbara Tóth, Imola Fejes, Anna Vágvölgyi, Dezső Csupor
Not first-line antihypertensive agents, but still effective-The efficacy and safety of imidazoline receptor agonists: A network meta-analysis. Pharmacology research & perspectives 12 (3) (2024)
Ikhwan Yuda Kusuma, Habibie Habibie, Muh Akbar Bahar, Ferenc Budan, Dezső Csupor
Anticancer Effects of Secoiridoids-A Scoping Review of the Molecular Mechanisms behind the Chemopreventive Effects of the Olive Tree Components Oleocanthal, Oleacein, and Oleuropein. Nutrients 16 (16) (2024)
András Érszegi, Réka Viola, Muh Akbar Bahar, Barbara Tóth, Imola Fejes, Anna Vágvölgyi, Dezső Csupor
Not first-line antihypertensive agents, but still effective-The efficacy and safety of imidazoline receptor agonists: A network meta-analysis. Pharmacology research & perspectives 12 (3) (2024)
András Érszegi, Réka Viola, Muh Akbar Bahar, Barbara Tóth, Imola Fejes, Anna Vágvölgyi, Dezső Csupor
Not first-line antihypertensive agents, but still effective-The efficacy and safety of imidazoline receptor agonists: A network meta-analysis. Pharmacology research & perspectives 12 (3) (2024)
Silma Kaaffah, Ikhwan Yuda Kusuma, Fransiskus Samuel Renaldi, Yovita Endah Lestari, Arik Dian Eka Pratiwi, Muh Akbar Bahar
Knowledge, Attitudes, and Perceptions of Tuberculosis in Indonesia: A Multi-Center Cross-Sectional Study. Infection and drug resistance 16 (2023)
Mersa Nurain Kausar, Efi Fitriana, Khairunnisa Khairunnisa, Md Omar Faruque, Muh Akbar Bahar, Sofa Dewi Alfian, Ivan Surya Pradipta
Development and Validation of the Knowledge, Attitude, and Practice Questionnaire for Community Pharmacy Personnel in Tuberculosis Case Detection, Drug Monitoring, and Education: A Study from Indonesia. Infection and drug resistance 16 (2023)
Dorottya Koncz, Barbara Tóth, Muh Akbar Bahar, Orsolya Roza, Dezső Csupor
The Safety and Efficacy of Citrus aurantium (Bitter Orange) Extracts and p -Synephrine: A Systematic Review and Meta-Analysis. Nutrients 14 (19) (2022)
Firzan Nainu, Ayu Masyita, Muh Akbar Bahar, Muhammad Raihan, Shajuthi Rahman Prova, Saikat Mitra, Talhah Bin Emran, Bernabé Nuñez-Estevez
Pharmaceutical Prospects of Bee Products: Special Focus on Anticancer, Antibacterial, Antiviral, and Antiparasitic Properties. Antibiotics (Basel, Switzerland) 10 (7) (2021)
Muh Akbar Bahar, Pauline Lanting, Jens H J Bos, Rolf H Sijmons, Eelko Hak, Bob Wilffert
Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative. Journal of personalized medicine 10 (4) (2020)
Muh Akbar Bahar, Jasper Kamp, Sander D Borgsteede, Eelko Hak, Bob Wilffert
The impact of CYP2D6 mediated drug-drug interaction: a systematic review on a combination of metoprolol and paroxetine/fluoxetine. British journal of clinical pharmacology 84 (12) (2018)
Muh Akbar Bahar, Yuanyuan Wang, Jens H J Bos, Bob Wilffert, Eelko Hak
Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly. Pharmacoepidemiology and drug safety 27 (6) (2018)
Muh Akbar Bahar, Eelko Hak, Jens H J Bos, Sander D Borgsteede, Bob Wilffert
The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly. Pharmacoepidemiology and drug safety 26 (7) (2017)

Muh Akbar Bahar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Muh Akbar Bahar